The DOI matches its Crossref record; 219 of the 219 references it cites were found in a registry or an index.
Molecular Pharmacology of VEGF-A Isoforms: Binding and Signalling at VEGFR2
Open accessAbstract
Vascular endothelial growth factor-A (VEGF-A) is a key mediator of angiogenesis, signalling via the class IV tyrosine kinase receptor family of VEGF Receptors (VEGFRs). Although VEGF-A ligands bind to both VEGFR1 and VEGFR2, they primarily signal via VEGFR2 leading to endothelial cell proliferation, survival, migration and vascular permeability. Distinct VEGF-A isoforms result from alternative splicing of the Vegfa gene at exon 8, resulting in VEGFxxxa or VEGFxxxb isoforms. Alternative splicing events at exons 5–7, in addition to recently identified posttranslational read-through events, produce VEGF-A isoforms that differ in their bioavailability and interaction with the co-receptor Neuropilin-1. This review explores the molecular pharmacology of VEGF-A isoforms at VEGFR2 in respect to ligand binding and downstream signalling. To understand how VEGF-A isoforms have distinct signalling despite similar affinities for VEGFR2, this review re-evaluates the typical classification of these isoforms relative to the prototypical, “pro-angiogenic” VEGF165a. We also examine the molecular mechanisms underpinning the regulation of VEGF-A isoform signalling and the importance of interactions with other membrane and extracellular matrix proteins. As approved therapeutics targeting the VEGF-A/VEGFR signalling axis largely lack long-term efficacy, understanding these isoform-specific mechanisms could aid future drug discovery efforts targeting VEGF receptor pharmacology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–219 of 219
Pang, V., Bates, D. O., & Leach, L. (2017) · Clinical Science · doi:10.1042/cs20171252 · Cited by 34
Ye, X., Abou-Rayyah, Y., Bischoff, J. E., Ritchie, A., Sebire, N. J., Watts, P., Churchill, A., & Bates, D. O. (2016) · The Journal of Pathology · doi:10.1002/path.4715 · Cited by 33
VEGF-A121a binding to Neuropilins – A concept revisited
Sarabipour, S., & Gabhann, F. M. (2017) · Cell Adhesion & Migration · doi:10.1080/19336918.2017.1372878 · Cited by 33
Fearnley, G. W., Bruns, A. F., Wheatcroft, S. B., & Ponnambalam, S. (2015) · Biology Open · doi:10.1242/bio.201410884 · Cited by 32
A computational analysis of in vivo VEGFR activation by multiple co-expressed ligands
Clegg, L. E., & Gabhann, F. M. (2017) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1005445 · Cited by 32
Autocrine VEGF Isoforms Differentially Regulate Endothelial Cell Behavior
Yamamoto, H., Rundqvist, H., Branco, C. M., & Johnson, R. S. (2016) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2016.00099 · Cited by 31
Hueso, L., Ríos‐Navarro, C., Ruiz‐Saurí, A., Chorro, F. J., Núñez, J. E., Sanz, M., Bodı́, V., & Piqueras, L. (2017) · Scientific Reports · doi:10.1038/s41598-017-10505-9 · Cited by 31
Nieminen, T., Toivanen, P. I., Rintanen, N., Heikura, T., Jauhiainen, S., Airenne, K. J., Alitalo, K. K., Marjomäki, V., & Ylä‐Herttuala, S. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.10.005 · Cited by 26
Danastas, K., Miller, E. J., Hey‐Cunningham, A. J., Murphy, C. R., & Lindsay, L. A. (2017) · Reproduction Fertility and Development · doi:10.1071/rd17184 · Cited by 26
Bridgett, S., Dellett, M., & Simpson, D. A. C. (2017) · Scientific Reports · doi:10.1038/s41598-017-00100-3 · Cited by 25
Carter, J. J., Fretwell, L., & Woolard, J. (2016) · The FASEB Journal · doi:10.1096/fj.201600749r · Cited by 22
Self-citationManni, S., Kisko, K., Schleier, T., Missimer, J., & Ballmer‐Hofer, K. (2014) · The FASEB Journal · doi:10.1096/fj.14-256206 · Cited by 19
Shi-ying, W., Boyun, S., Jianye, Y., Wanjun, Z., Tao, P., Lin, J., & Hu, H. (2017) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000001055 · Cited by 19
VEGF111b, a new member of VEGFxxxb isoforms and induced by mitomycin C, inhibits angiogenesis
Gu, F., Li, X., Kong, J., Pan, B., Sun, M., Zheng, L., & Yao, Y. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.09.144 · Cited by 18
Angiogenic response following renal ischemia reperfusion injury: new players
Pallet, N., Thervet, É., & Timsit, M. (2014) · The French Journal of Urology · doi:10.1016/s1166-7087(14)70059-4 · Cited by 18
Shibata, Y., Kikuchi, R., Ishii, H., Suzuki, S., Harada, K., Hirayama, K., Suzuki, A., Tatami, Y., Kondo, K., & Murohara, T. (2017) · Clinica Chimica Acta · doi:10.1016/j.cca.2017.12.042 · Cited by 18
NRP-1 expression is strongly associated with the progression of pituitary adenomas
Lee, S., Lee, J. E., Yoo, C. Y., et al. (2014) · Oncology Reports · doi:10.3892/or.2014.3392 · Cited by 17
Chemotherapy induces alternative transcription and splicing: Facts and hopes for cancer treatment
Lambert, C. A., Garbacki, N., & Colige, A. (2017) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2017.04.006 · Cited by 16
Expression Patterns of VEGF and Flk-1 in Human Endometrium during the Menstrual Cycle.
Lai, T. H., Vlahos, N., Shih, I., & Zhao, Y. (2015) · Europe PMC (PubMed Central) · Cited by 15
Cited by
Angiogenic signaling pathways and anti-angiogenic therapy for cancer
Liu, Z.-L., Chen, H.-H., Zheng, L.-L., Sun, L.-P., & Shi, L. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01460-1 · Cited by 1,300
Nanocomposite scaffolds for accelerating chronic wound healing by enhancing angiogenesis
Nosrati, H., Aramideh Khouy, R., Nosrati, A., Khodaei, M., Banitalebi-Dehkordi, M., Ashrafi-Dehkordi, K., Sanami, S., & Alizadeh, Z. (2021) · Journal of Nanobiotechnology · doi:10.1186/s12951-020-00755-7 · Cited by 720
Lee, C., Kim, M.-J., Kumar, A., Lee, H.-W., Yang, Y., & Kim, Y. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02249-0 · Cited by 365
VEGFR1 signaling in retinal angiogenesis and microinflammation
Uemura, A., Fruttiger, M., D'Amore, P. A., De Falco, S., Joussen, A. M., Sennlaub, F., Brunck, L. R., Johnson, K. T., Lambrou, G. N., Rittenhouse, K. D., et al. (2021) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2021.100954 · Cited by 354
Diabetic Macular Edema: Current Understanding, Molecular Mechanisms and Therapeutic Implications
Zhang, J., Zhang, J., Zhang, C., Zhang, J., Gu, L., Luo, D., & Qiu, Q. (2022) · Cells · doi:10.3390/cells11213362 · Cited by 300
Metadata
- Authors
- Peach, C. J., Mignone, V. W., Arruda, M. A., Alcobia, D. C., Hill, S. J., Kilpatrick, L. E., & Woolard, J.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2018-04-23
- Volume
- 19
- Issue
- 4
- Pages
- 1264
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W2802868810
- Cited by
- 512
- References
- 219
- FWCI
- 12.63
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.